Last edition
News about Market
Emcure's Marcan Pharma to Acquire Remaining Stake in Mantra Pharma
Emcure Pharmaceuticals' subsidiary Marcan Pharmaceuticals has signed agreements to acquire the remaining Class E Special Shares of Canada's Mantra Pharma, making the company a wholly owned subsidiary.
Market | 06/07/2026 | By News Bureau
Oliva Therapeutics to Commercially Launch Amerithroid for Hypothyroidism Treatment
Oliva Therapeutics is set to launch Amerithroid, a US-manufactured desiccated thyroid extract developed in partnership with Jerome Stevens Pharmaceuticals, strengthening its endocrine care portfolio with a naturally derived treatment for hypothyroidism.
Market | 06/07/2026 | By News Bureau
Glenmark Pharmaceuticals Launches Olanzapine for Injection 10 mg/vial Single-Dose Vial in US
Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection 10 mg/vial, a bioequivalent and therapeutically equivalent generic to Zyprexa IntraMuscular Injection.
Market | 06/07/2026 | By Akanki
Samsung Bioepis Relaunches Byooviz in US Through Commercial Partnership with Harrow
Samsung Bioepis has relaunched its ophthalmology biosimilar Byooviz in the US through its partnership with Harrow, expanding access to a lower-cost treatment option for patients with retinal diseases, including wet age-related macular degeneration.
Market | 03/07/2026 | By News Bureau
Mankind Pharma Partners with Denovo Sciences to Accelerate AI-Driven Drug Discovery
The collaboration between Mankind Pharma and Denovo Sciences launches AI-powered drug discovery to accelerate research timelines and improve lead candidate quality.
Market | 02/07/2026 | By News Bureau
Innovent and Lilly Partner to Commercialise Verzenios in China
Innovent Biologics and Eli Lilly have signed a commercialisation agreement for Verzenios (abemaciclib) in mainland China, expanding access to the CDK4/6 inhibitor for cancer patients.
Market | 01/07/2026 | By News Bureau
Jagsonpal Pharmaceuticals to Acquire 85 Percent Stake in Aequitas Healthcare for INR 20.8 Crore
Aeguitas Healthcare’s acquisition marks Jagsonpal's entry into the hospital pharmaceutical segment, strengthening its omnichannel healthcare strategy and expanding its institutional market presence.
Market | 01/07/2026 | By News Bureau
Cadila Pharmaceuticals and Singapore-based Wellesta Holdings have signed an MoU to establish a joint venture focused on expanding access to high-quality healthcare solutions across Southeast Asia and other emerging markets.
Market | 01/07/2026 | By News Bureau
Morepen Begins Commercial Supplies under INR 825 Crore CDMO Contract
Morepen has started commercial supplies under its INR 825 crore CDMO mandate, completing the first INR 50 crore dispatch in Q1 FY2026-27 and strengthening its contract manufacturing business.
Market | 01/07/2026 | By News Bureau
Aurobindo Pharma USA Completes Acquisition of Lannett Company
Aurobindo Pharma USA has completed the acquisition of Lannett Company after securing approval from the US Federal Trade Commission. Effective June 29, 2026, Lannett will operate as Lannett Company LLC, with the combined entity aiming to strengthen the supply of essential medicines and enhance value for patients and customers.
Market | 30/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy